Absence of premature senescence in Werner's syndrome keratinocytes
- PMID: 27492502
- DOI: 10.1016/j.exger.2016.07.017
Absence of premature senescence in Werner's syndrome keratinocytes
Abstract
Werner's syndrome (WS) is an autosomal recessive genetic disorder caused by loss of function mutation in wrn and is a useful model of premature in vivo ageing. Cellular senescence is a plausible causal mechanism of mammalian ageing and, at the cellular level, WS fibroblasts show premature senescence resulting from a combination of telomeric attrition and replication fork stalling. Over 90% of WS fibroblast cultures achieve <20 population doublings (PD) in vitro compared to wild type human fibroblast cultures. It has been proposed that some cell types, capable of proliferation, will fail to show a premature senescence phenotype in response to wrn mutations. To test this hypothesis, human dermal keratinocytes (derived from both WS and wild type patients) were cultured long term. WS Keratinocytes showed a replicative lifespan in excess of 100 population doublings but maintained functional growth arrest mechanisms based on p16 and p53. The karyotype of the cells was superficially normal and the cultures retained markers characteristic of keratinocyte holoclones (stem cells) including p63 expression and telomerase activity. Accordingly we conclude that, in contrast to WS fibroblasts, WS keratinocytes do not demonstrate slow growth rates or features of premature senescence. These findings suggest that the epidermis is among the tissue types that do not display symptoms of premature ageing caused by loss of function of wrn. This is in support that Werner's syndrome is a segmental progeroid syndrome.
Keywords: Ageing; Cellular senescence; Fibroblasts; Keratinocytes; Werner's syndrome; p53; p63.
Copyright © 2016 Elsevier Inc. All rights reserved.
Similar articles
-
A model for the phenotypic presentation of Werner's syndrome.Exp Gerontol. 2002 Jan-Mar;37(2-3):285-92. doi: 10.1016/s0531-5565(01)00194-2. Exp Gerontol. 2002. PMID: 11772514 Review.
-
Asymmetry of DNA replication fork progression in Werner's syndrome.Aging Cell. 2002 Oct;1(1):30-9. doi: 10.1046/j.1474-9728.2002.00002.x. Aging Cell. 2002. PMID: 12882351
-
Werner's syndrome T lymphocytes display a normal in vitro life-span.Mech Ageing Dev. 2000 Dec 20;121(1-3):139-49. doi: 10.1016/s0047-6374(00)00205-0. Mech Ageing Dev. 2000. PMID: 11164468
-
Characterisation of the interaction between WRN, the helicase/exonuclease defective in progeroid Werner's syndrome, and an essential replication factor, PCNA.Mech Ageing Dev. 2003 Feb;124(2):167-74. doi: 10.1016/s0047-6374(02)00131-8. Mech Ageing Dev. 2003. PMID: 12633936
-
Werner's syndrome: from clinics to genetics.Clin Exp Rheumatol. 2000 Nov-Dec;18(6):760-6. Clin Exp Rheumatol. 2000. PMID: 11138345 Review.
Cited by
-
Recent Advances in Understanding Werner Syndrome.F1000Res. 2017 Sep 28;6:1779. doi: 10.12688/f1000research.12110.1. eCollection 2017. F1000Res. 2017. PMID: 29043077 Free PMC article. Review.
-
Tissue engineering strategies to bioengineer the ageing skin phenotype in vitro.Aging Cell. 2022 Feb;21(2):e13550. doi: 10.1111/acel.13550. Epub 2022 Jan 17. Aging Cell. 2022. PMID: 35037366 Free PMC article. Review.
-
Telomeres and Telomerase in the Control of Stem Cells.Biomedicines. 2022 Sep 20;10(10):2335. doi: 10.3390/biomedicines10102335. Biomedicines. 2022. PMID: 36289597 Free PMC article. Review.
-
Genetic correction of Werner syndrome gene reveals impaired pro-angiogenic function and HGF insufficiency in mesenchymal stem cells.Aging Cell. 2020 May;19(5):e13116. doi: 10.1111/acel.13116. Epub 2020 Apr 22. Aging Cell. 2020. PMID: 32320127 Free PMC article.
-
Research on Werner Syndrome: Trends from Past to Present and Future Prospects.Genes (Basel). 2022 Oct 6;13(10):1802. doi: 10.3390/genes13101802. Genes (Basel). 2022. PMID: 36292687 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous